Click Therapeutics' digital therapeutic (DTx) CT-132 has been approved by the FDA, becoming the first treatment of its type in the US for preventing attacks in people with episodic migraine. The ...
A digital therapeutic (DTx) that aims to treat negative symptoms of schizophrenia, like apathy and social withdrawal, has hit the target in a phase 3 trial. The smartphone-based CT-155 app, ...
Click Holdings Limited provides human resources solutions in Hong Kong. It operates through three segments: Professional Solution Services, Nursing Solution Services, and Logistics and Other Solution ...
ConsumerAffairs is not a government agency. Companies displayed may pay us to be Authorized or when you click a link, call a number or fill a form on our site. Our content is intended to be used for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results